Item 1. Financial Statements
113K characters. Original on sec.gov ·
Item 1. Financial Statements
| --- | --- |
TERADYNE, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
| April 3, 2022 | December 31, 2021 | |||||||
| (in thousands, except per share amount) | ||||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 794,603 | $ | 1,122,199 | ||||
| Marketable securities | 282,016 | 244,231 | ||||||
| Accounts receivable, less allowance for credit losses of $1,891 and $2,012 at April 3, 2022 and December 31, 2021, respectively | 546,881 | 550,749 | ||||||
| Inventories, net | 259,341 | 243,330 | ||||||
| Prepayments | 479,414 | 406,266 | ||||||
| Other current assets | 12,127 | 9,452 | ||||||
| Total current assets | 2,374,382 | 2,576,227 | ||||||
| Property, plant and equipment, net | 399,485 | 387,240 | ||||||
| Operating lease right-of-use assets, net | 67,718 | 68,807 | ||||||
| Marketable securities | 126,130 | 133,858 | ||||||
| Deferred tax assets | 113,556 | 102,428 | ||||||
| Retirement plans assets | 14,669 | 15,110 | ||||||
| Other assets | 23,480 | 24,096 | ||||||
| Acquired intangible assets, net | 69,846 | 75,635 | ||||||
| Goodwill | 419,888 | 426,024 | ||||||
| Total assets | $ | 3,609,154 | $ | 3,809,425 | ||||
| LIABILITIES | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 156,493 | $ | 153,133 | ||||
| Accrued employees’ compensation and withholdings | 139,287 | 253,667 | ||||||
| Deferred revenue and customer advances | 155,761 | 146,185 | ||||||
| Other accrued liabilities | 118,252 | 124,187 | ||||||
| Operating lease liabilities | 18,523 | 19,977 | ||||||
| Income taxes payable | 103,386 | 88,789 | ||||||
| Current debt | 20,497 | 19,182 | ||||||
| Total current liabilities | 712,199 | 805,120 | ||||||
| Retirement plans liabilities | 151,697 | 151,141 | ||||||
| Long-term deferred revenue and customer advances | 51,698 | 54,921 | ||||||
| Long-term other accrued liabilities | 15,748 | 15,497 | ||||||
| Deferred tax liabilities | 4,927 | 6,327 | ||||||
| Long-term operating lease liabilities | 55,934 | 56,178 | ||||||
| Long-term incomes taxes payable | 67,041 | 67,041 | ||||||
| Debt | 75,378 | 89,244 | ||||||
| Total liabilities | 1,134,622 | 1,245,469 | ||||||
| Commitments and contingencies ( N ote Q ) | ||||||||
| Mezzanine equity: | ||||||||
| Convertible common shares | — | 1,512 | ||||||
| SHAREHOLDERS’ EQUITY | ||||||||
| Common stock, $0.125 par value, 1,000,000 shares authorized; 161,053 and 162,251 shares issued and outstanding at April 3, 2022 and December 31, 2021, respectively | 20,132 | 20,281 | ||||||
| Additional paid-in capital | 1,711,690 | 1,811,545 | ||||||
| Accumulated other comprehensive loss | (19,479 | ) | (5,948 | ) | ||||
| Retained earnings | 762,189 | 736,566 | ||||||
| Total shareholders’ equity | 2,474,532 | 2,562,444 | ||||||
| Total liabilities, convertible common shares and shareholders’ equity | $ | 3,609,154 | $ | 3,809,425 | ||||
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s Annual Report
on Form
10-K
for the year ended December 31, 2021, are an integral part of the condensed consolidated financial statements.
TERADYNE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
| For the Three Months Ended | ||||||||
| April 3, 2022 | April 4, 2021 | |||||||
| (in thousands, except per share amount) | ||||||||
| Revenues: | ||||||||
| Products | $ | 625,875 | $ | 660,508 | ||||
| Services | 129,495 | 121,098 | ||||||
| Total revenues | 755,370 | 781,606 | ||||||
| Cost of revenues: | ||||||||
| Cost of products | 243,016 | 267,784 | ||||||
| Cost of services | 57,421 | 52,204 | ||||||
| Total cost of revenues (exclusive of acquired intangible assets amortization shown separately below) | 300,437 | 319,988 | ||||||
| Gross profit | 454,933 | 461,618 | ||||||
| Operating expenses: | ||||||||
| Selling and administrative | 140,185 | 129,797 | ||||||
| Engineering and development | 108,116 | 100,402 | ||||||
| Acquired intangible assets amortization | 5,063 | 5,536 | ||||||
| Restructuring and other | 15,714 | (7,130 | ) | |||||
| Total operating expenses | 269,078 | 228,605 | ||||||
| Income from operations | 185,855 | 233,013 | ||||||
| Non-operating (income) expense: | ||||||||
| Interest income | (703 | ) | (808 | ) | ||||
| Interest expense | 1,012 | 6,004 | ||||||
| Other (income) expense, net | 5,187 | 3,824 | ||||||
| Income before income taxes | 180,359 | 223,993 | ||||||
| Income tax provision | 18,431 | 18,481 | ||||||
| Net income | $ | 161,928 | $ | 205,512 | ||||
| Net income per common share: | ||||||||
| Basic | $ | 1.00 | $ | 1.23 | ||||
| Diluted | $ | 0.92 | $ | 1.09 | ||||
| Weighted average common shares—basic | 162,048 | 166,491 | ||||||
| Weighted average common shares—diluted | 175,575 | 187,740 | ||||||
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s
Annual Report on Form
10-K
for the year ended December 31, 2021, are an integral part of the condensed
consolidated financial statements.
TERADYNE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
| For the Three Months Ended | ||||||||
| April 3, 2022 | April 4, 2021 | |||||||
| (in thousands) | ||||||||
| Net income | $ | 161,928 | $205,512 | |||||
| Other comprehensive income, net of tax: | ||||||||
| Foreign currency translation adjustment, net of tax of $0 and $0, respectively | (8,076 | ) | (21,123 | ) | ||||
| Available-for-sale marketable securities: | ||||||||
| Unrealized losses on marketable securities arising during period, net of tax of $(1,333) and $(908), respectively | (5,388 | ) | (3,270 | ) | ||||
| Less: Reclassification adjustment for gains included in net income, net of tax of $(18) and $(123), respectively | (65 | ) | (444 | ) | ||||
| (5,453 | ) | (3,714 | ) | |||||
| Defined benefit post-retirement plan: | ||||||||
| Amortization of prior service credit, net of tax of $0 and $0, respectively | (2 | ) | (2 | ) | ||||
| Other comprehensive loss | (13,531 | ) | (24,839 | ) | ||||
| Comprehensive income | $148,397 | $180,673 | ||||||
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s
Annual Report on Form
10-K
for the year ended December 31, 2021, are an integral part of the condensed
consolidated financial statements.
TERADYNE, INC.
CONDENSED STATEMENTS OF CONVERTIBLE COMMON SHARES
AND SHAREHOLDERS’ EQUITY
(Unaudited)
| Shareholders’ Equity | ||||||||||||||||||||||||||||
| Convertible Common Shares Value | Common Stock Shares | Common Stock Par Value | Additional Paid-in Capital | Accumulated Other Comprehensive (Loss) Income | Retained Earnings | Total Shareholders’ Equity | ||||||||||||||||||||||
| (in thousands) | ||||||||||||||||||||||||||||
| For the Three Months Ended April 3, 2022 | ||||||||||||||||||||||||||||
| Balance, December 31, 2021 | $ | 1,512 | 162,251 | $ | 20,281 | $ | 1,811,545 | $ | (5,948 | ) | $ | 736,566 | $ | 2,562,444 | ||||||||||||||
| Net issuance of common stock under stock-based plans | 552 | 70 | (14,644 | ) | (14,574 | ) | ||||||||||||||||||||||
| Stock-based compensation expense | 14,204 | 14,204 | ||||||||||||||||||||||||||
| Repurchase of common stock | (1,750 | ) | (219 | ) | (211,247 | ) | (211,466 | ) | ||||||||||||||||||||
| Cash dividends ($0.11 per share) | (17,908 | ) | (17,908 | ) | ||||||||||||||||||||||||
| Settlements of convertible notes | 509 | 64 | (157 | ) | (93 | ) | ||||||||||||||||||||||
| Exercise of convertible notes hedge call options | (509 | ) | (64 | ) | 64 | — | ||||||||||||||||||||||
| Cumulative-effect of change in accounting principle related to convertible debt | (1,512 | ) | (99,322 | ) | 92,850 | (6,472 | ) | |||||||||||||||||||||
| Net income | 161,928 | 161,928 | ||||||||||||||||||||||||||
| Other comprehensive loss | (13,531 | ) | (13,531 | ) | ||||||||||||||||||||||||
| Balance, April 3, 2022 | $ | — | 161,053 | $ | 20,132 | $ | 1,711,690 | $ | (19,479 | ) | $ | 762,189 | $ | 2,474,532 | ||||||||||||||
| For the Three Months Ended April 4, 2021 | ||||||||||||||||||||||||||||
| Balance, December 31, 2020 | $ | 3,787 | 166,123 | $ | 20,765 | $ | 1,765,323 | $ | 33,516 | $ | 387,414 | $ | 2,207,018 | |||||||||||||||
| Net issuance of common stock under stock-based plans | 670 | 84 | (14,071 | ) | (13,987 | ) | ||||||||||||||||||||||
| Stock-based compensation expense | 13,359 | 13,359 | ||||||||||||||||||||||||||
| Repurchase of common stock | (374 | ) | (47 | ) | (47,141 | ) | (47,188 | ) | ||||||||||||||||||||
| Cash dividends ($0.10 per share) | (16,682 | ) | (16,682 | ) | ||||||||||||||||||||||||
| Settlements of convertible notes | 1,222 | 153 | 157,529 | 157,682 | ||||||||||||||||||||||||
| Exercise of convertible notes hedge call options | (1,222 | ) | (153 | ) | (158,723 | ) | (158,876 | ) | ||||||||||||||||||||
| Convertible common shares | (2,554 | ) | 2,554 | 2,554 | ||||||||||||||||||||||||
| Net income | 205,512 | 205,512 | ||||||||||||||||||||||||||
| Other comprehensive loss | (24,839 | ) | (24,839 | ) | ||||||||||||||||||||||||
| Balance, April 4, 2021 | $ | 1,233 | 166,419 | $ | 20,802 | $ | 1,765,971 | $ | 8,677 | $ | 529,103 | $ | 2,324,553 | |||||||||||||||
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s
Annual Report on Form
10-K
for the year ended December 31, 2021, are an integral part of the condensed
consolidated financial statements.
TERADYNE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
| For the Three Months Ended | ||||||||
| April 3, 2022 | April 4, 2021 | |||||||
| (in thousands) | ||||||||
| Cash flows from operating activities: | ||||||||
| Net income | $ | 161,928 | $ | 205,512 | ||||
| Adjustments to reconcile net income from operations to net cash provided by operating activities: | ||||||||
| Depreciation | 22,503 | 23,910 | ||||||
| Stock-based compensation | 12,894 | 12,232 | ||||||
| Amortization | 5,233 | 9,822 | ||||||
| Deferred taxes | 11,288 | (1,057 | ) | |||||
| Losses (gains) on investments | 2,001 | (2,491 | ) | |||||
| Provision for excess and obsolete inventory | 1,590 | 2,285 | ||||||
| Loss on convertible debt conversion s | — | 4,069 | ||||||
| Contingent consideration fair value adjustment s | — | (7,227 | ) | |||||
| Other | 177 | 200 | ||||||
| Changes in operating assets and liabilities | ||||||||
| Accounts receivable | 208 | (87,512 | ) | |||||
| Inventories | (9,480 | ) | (35,870 | ) | ||||
| Prepayments and other assets | (74,305 | ) | (86,131 | ) | ||||
| Accounts payable and other accrued expenses | (124,382 | ) | (10,571 | ) | ||||
| Deferred revenue and customer advances | 6,747 | 7,952 | ||||||
| Retirement plan contributions | (1,329 | ) | (1,925 | ) | ||||
| Income taxes | (7,611 | ) | 4,941 | |||||
| Net cash provided by operating activities | 7,462 | 38,139 | ||||||
| Cash flows from investing activities: | ||||||||
| Purchases of property, plant and equipment | (43,999 | ) | (39,250 | ) | ||||
| Purchases of marketable securities | (165,977 | ) | (211,604 | ) | ||||
| Proceeds from maturities of marketable securities | 96,682 | 194,228 | ||||||
| Proceeds from sales of marketable securities | 30,581 | 61,293 | ||||||
| Net cash (used for) provided by investing activities | (82,713 | ) | 4,667 | |||||
| Cash flows from financing activities: | ||||||||
| Issuance of common stock under stock purchase and stock option plans | 16,475 | 17,144 | ||||||
| Repurchase of common stock | (201,465 | ) | (45,188 | ) | ||||
| Payments related to net settlement of employee stock compensation awards | (31,048 | ) | (30,675 | ) | ||||
| Payments of convertible debt principal | (20,694 | ) | (51,275 | ) | ||||
| Dividend payments | (17,895 | ) | (16,667 | ) | ||||
| Net cash used for financing activities | (254,627 | ) | (126,661 | ) | ||||
| Effects of exchange rate changes on cash and cash equivalents | 2,282 | 883 | ||||||
| Decrease in cash and cash equivalents | (327,596 | ) | (82,972 | ) | ||||
| Cash and cash equivalents at beginning of period | 1,122,199 | 914,121 | ||||||
| Cash and cash equivalents at end of period | $ | 794,603 | $ | 831,149 | ||||
| Non-cash investing activities: | ||||||||
| Capital expenditures incurred but not yet paid: | $ | 2,500 | $ | 3,840 |
The accompanying notes, together with the Notes to Consolidated Financial Statements included in Teradyne’s
Annual Report on Form
10-K
for the year ended December 31, 2021, are an integral part of the condensed
consolidated financial statements.
TERADYNE, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
A. THE COMPANY
Teradyne, Inc. (“Teradyne”) is a leading global supplier of automation equipment for test and industrial applications. Teradyne designs, develops, manufactures and sells automatic test systems used to test semiconductors, wireless products, data storage and complex electronics systems in many industries including consumer electronics, wireless, automotive, industrial, computing, communications, and aerospace and defense industries. Teradyne’s industrial automation products include collaborative robotic arms, autonomous mobile robots, and advanced robotic control software used by global manufacturing, logistics and light industrial customers to improve quality, increase manufacturing and material handling efficiency and decrease manufacturing and logistics costs. Teradyne’s automatic test equipment and industrial automation products and services include:
| • | semiconductor test (“Semiconductor Test”) systems; |
|---|
| • | storage and system level test (“Storage Test”) systems, defense/aerospace (“Defense/Aerospace”) test instrumentation and systems, and circuit-board test and inspection (“Production Board Test”) systems (collectively these products represent “System Test”); |
|---|
| • | wireless test (“Wireless Test”) systems; and |
|---|
| • | industrial automation (“Industrial Automation”) products. |
|---|
B. ACCOUNTING POLICIES
Basis of Presentation
The consolidated interim financial statements include the accounts of Teradyne and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated. These interim financial statements are unaudited and reflect all normal recurring adjustments that are, in the opinion of management, necessary for the fair statement of such interim financial statements. Certain prior year amounts may have been reclassified to conform to the current year presentation. The December 31, 2021 condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by United States of America generally accepted accounting principles (“U.S. GAAP”) for complete financial statements. The accompanying financial information should be read in conjunction with the consolidated financial statements and notes thereto contained in Teradyne’s Annual Report on Form
10-K,
filed with the U.S. Securities and Exchange Commission (“SEC”) on February 23, 2022, for the year ended December 31, 2021.
Preparation of Financial Statements and Use of Estimates
The preparation of consolidated financial statements requires management to make estimates and judgments that affect the amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent liabilities. On an
on-going
basis, management evaluates its estimates, including those related to inventories, investments, goodwill, intangible and other long-lived assets, accounts receivable, income taxes, deferred tax assets and liabilities, pensions, warranties, and loss contingencies. Management bases its estimates on historical experience and on appropriate and customary assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgements about the carrying values of assets and liabilities that are not readily apparent from other sources. Due to the
COVID-19
pandemic, there has been uncertainty and disruption in the global economy and our markets. Management is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of this Quarterly Report on Form
10-Q.
These estimates may change, as new events occur and additional information is obtained. Actual results may differ significantly from these estimates under different assumptions or conditions.
Convertible Debt
Teradyne adopted Accounting Standards Update (“ASU”) ASU
2020-06
–
“Debt—Debt with Conversion and Other Options and Derivatives and Hedging—Contracts in Entity’s Own Equity,”
on January 1, 2022 using the modified retrospective method of adoption
.
Under ASU
2020-06,
Teradyne accounts for a convertible debt instrument as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. Unsettled shares are recorded in current debt, and there is no recognition of a debt discount, which was previously amortized to interest expense. Teradyne uses the
if-converted
method in the diluted earnings per share (“EPS”) calculation for convertible instruments. As a result of adoption, Teradyne recorded an increase
of
$1.4 million to current debt for unsettled shares, an increase of $6.6 million to long-term
debt
for unamortized debt discount, and an increase to retained earnings of $92.8 million for the reclassification of the equity component. Mezzanine equity representing unsettled shares value was reduced to zero and additional
paid-in
capital was reduced by $99.3 million.
C. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS
For the three months ended April 3, 2022, there were no recently issued accounting pronouncements that had, or are expected to have, a material impact to Teradyne’s consolidated financial statements.
D. INVESTMENT IN OTHER COMPANY
On June 1, 2021, Teradyne invested $12.0 million in MachineMetrics, Inc. (“MachineMetrics”), a private company that develops and sells products to improve manufacturing performance through automated machine data collection, alerting, and analytics. Teradyne’s investment in MachineMetrics aligns with its strategy of providing and investing in leading edge products for automating industrial production processes in growing markets. The investment was recorded at cost and is evaluated for impairment or an indication of changes in fair value resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer on a quarterly basis. At April 3, 2022, the value of the investment was $12.0 million, and there was no change during the three months ended April 3, 2022.
E. REVENUE
Disaggregation of Revenue
The following table provides information about disaggregated revenue by timing of revenue recognition, primary geographical market, and major product lines.
| Semiconductor Test | Industrial Automation | |||||||||||||||||||||||||||||||||||
| System on-a- Chip | Memory | System Test | Universal Robots | Mobile Industrial Robots | AutoGuide | Wireless Test | Corporate and Eliminations | Total | ||||||||||||||||||||||||||||
| (in thousands) | ||||||||||||||||||||||||||||||||||||
| For the Three Months Ended April 3, 2022 (1) | ||||||||||||||||||||||||||||||||||||
| Timing of Revenue Recognition | ||||||||||||||||||||||||||||||||||||
| Point in Time | $ | 323,456 | $ | 88,723 | $ | 105,288 | $ | 83,182 | $ | 16,534 | $ | 210 | $ | 48,429 | $ | (346 | ) | $ | 665,476 | |||||||||||||||||
| Over Time | 63,129 | 7,033 | 13,380 | 2,102 | 674 | 487 | 3,089 | — | 89,894 | |||||||||||||||||||||||||||
| Total | $ | 386,585 | $ | 95,756 | $ | 118,668 | $ | 85,284 | $ | 17,208 | $ | 697 | $ | 51,518 | $ | (346 | ) | $ | 755,370 | |||||||||||||||||
| Geographical Market | ||||||||||||||||||||||||||||||||||||
| Asia Pacific | $ | 340,741 | $ | 93,151 | $ | 73,784 | $ | 18,621 | $ | 2,592 | $ | — | $ | 34,946 | $ | — | $ | 563,835 | ||||||||||||||||||
| Americas | 29,714 | 2,046 | 36,608 | 28,148 | 7,867 | 697 | 9,687 | (346 | ) | 114,421 | ||||||||||||||||||||||||||
| Europe, Middle East and Africa | 16,130 | 559 | 8,276 | 38,515 | 6,749 | — | 6,885 | — | 77,114 | |||||||||||||||||||||||||||
| Total | $ | 386,585 | $ | 95,756 | $ | 118,668 | $ | 85,284 | $ | 17,208 | $ | 697 | $ | 51,518 | $ | (346 | ) | $ | 755,370 | |||||||||||||||||
| For the Three Months Ended April 4, 2021 (1) | ||||||||||||||||||||||||||||||||||||
| Timing of Revenue Recognition | ||||||||||||||||||||||||||||||||||||
| Point in Time | $ | 364,190 | $ | 101,892 | $ | 119,314 | $ | 64,007 | $ | 14,064 | $ | (120 | ) | $ | 37,880 | $ | (143 | ) | $ | 701,084 | ||||||||||||||||
| Over Time | 56,040 | 5,941 | 13,523 | 1,594 | 67 | 339 | 3,018 | — | 80,522 | |||||||||||||||||||||||||||
| Total | $ | 420,230 | $ | 107,833 | $ | 132,837 | $ | 65,601 | $ | 14,131 | $ | 219 | $ | 40,898 | $ | (143 | ) | $ | 781,606 | |||||||||||||||||
| Geographical Market | ||||||||||||||||||||||||||||||||||||
| Asia Pacific | $ | 387,236 | $ | 104,049 | $ | 99,520 | $ | 17,833 | $ | 3,447 | $ | — | $ | 33,532 | $ | — | $ | 645,617 | ||||||||||||||||||
| Americas | 20,779 | 3,420 | 27,659 | 18,153 | 5,153 | 219 | 5,769 | (143 | ) | 81,009 | ||||||||||||||||||||||||||
| Europe, Middle East and Africa | 12,215 | 364 | 5,658 | 29,615 | 5,531 | — | 1,597 | — | 54,980 | |||||||||||||||||||||||||||
| Total | $ | 420,230 | $ | 107,833 | $ | 132,837 | $ | 65,601 | $ | 14,131 | $ | 219 | $ | 40,898 | $ | (143 | ) | $ | 781,606 | |||||||||||||||||
| (1) | Includes $2.3 million and $3.1 million in 2022 and 2021, respectively, for leases of Teradyne’s systems recognized outside Accounting Standards Codification (“ASC”) 606 “Revenue from Contracts with Customers.” |
|---|
Contract Balances
During the three months ended April 3, 2022 and April 4, 2021, Teradyne recognized $35.0 million and $27.8 million, respectively, that was previously included within the deferred revenue and customer advances balances at the beginning of the period. This revenue primarily relates to undelivered hardware, extended warranties, training, application support, and post contract support. Each of these represents a distinct performance obligation. As of April 3, 2022, Teradyne has $1,417.4 million of unsatisfied performance obligations. Teradyne expects to recognize 89% of the remaining performance obligations in the next 12 months
and
11% in
1-3
years.
Deferred revenue and customer advances consist of the following and are included in short and long-term deferred revenue and customer advances on the balance sheet:
| April 3, 2022 | December 31, 2021 | |||||||
| (in thousands) | ||||||||
| Maintenance, service and training | $ | 83,212 | $ | 81,826 | ||||
| Customer advances, undelivered elements and other | 58,521 | 55,112 | ||||||
| Extended warranty | 65,726 | 64,168 | ||||||
| Total deferred revenue and customer advances | $ | 207,459 | $ | 201,106 | ||||
Accounts Receivable
During the three months ended April 3, 2022 and April 4, 2021, Teradyne sold certain trade accounts receivables on a non-recourse basis to third-party financial institutions pursuant to factoring agreements. During the three months ended April 3, 2022 and April 4, 2021, total trade accounts receivable sold under the factoring agreements were
$19.4 million and $7.3 million
,
respectively. Factoring fees for the sales of receivables were recorded in interest expense and were not material. Teradyne accounted for these transactions as sales of receivables and presented cash proceeds as cash provided
by
operating activities in the consolidated statements of cash flows.
F. INVENTORIES
Inventories, net consisted of the following at April 3, 2022 and December 31, 2021:
| April 3, 2022 | December 31, 2021 | |||||||
| (in thousands) | ||||||||
| Raw material | $ | 187,856 | $ | 155,641 | ||||
| Work-in-process | 30,877 | 37,740 | ||||||
| Finished goods | 40,608 | 49,949 | ||||||
| $ | 259,341 | $ | 243,330 | |||||
Inventory reserves at April 3, 2022 and December 31, 2021 were $112.8 million and $114.1 million, respectively.
G. FINANCIAL INSTRUMENTS
Cash Equivalents
Teradyne considers all highly liquid investments with maturities of three months or less at the date of acquisition to be cash equivalents.
Marketable Securities
Teradyne’s
available-for-sale
debt securities are classified as Level 2 and equity and debt mutual funds are classified as Level 1. Contingent consideration is classified as Level 3. The vast majority of Level 2 securities are fixed income securities priced by third party pricing vendors. These pricing vendors utilize the most recent observable market information in pricing these securities or, if specific prices are not available, use other observable inputs like market transactions involving identical or comparable securities.
During the three months ended April 3, 2022 and April 4, 2021, there were no transfers in or out of Level 1, Level 2, or Level 3 financial instruments.
Realized gains recorded in the three months ended April 3, 2022 and April 4, 2021 were $0.4 million and $1.2 million, respectively. Realized losses recorded in the three months ended April 3, 2022 were $0.2 million. No realized losses were recorded in the three months ended April 4, 2021. Realized gains and losses are included in other (income) expense, net.
Unrealized losses on equity securities recorded in the three months ended April 3, 2022 were $2.2 million. Unrealized gains on equity securities recorded in the three months ended April 4, 2021 were $1.4 million. Unrealized gains and losses on equity securities are included in other (income) expense, net.
Unrealized gains and losses on
available-for-sale
debt securities are included in accumulated other comprehensive income (loss).
The cost of securities sold is based on average cost.
The following table sets forth by fair value hierarchy Teradyne’s financial assets and liabilities that were measured at fair value on a recurring basis as of April 3, 2022 and December 31, 2021.
| April 3, 2022 | ||||||||||||||||
| Quoted Prices in Active Markets for Identical Instruments (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | Total | |||||||||||||
| (in thousands) | ||||||||||||||||
| Assets | ||||||||||||||||
| Cash | $ | 508,245 | $ | — | $ | — | $ | 508,245 | ||||||||
| Cash equivalents | 212,647 | 73,711 | — | 286,358 | ||||||||||||
| Available-for-sale securities: | ||||||||||||||||
| Commercial paper | — | 179,481 | — | 179,481 | ||||||||||||
| U.S. Treasury securities | — | 119,837 | — | 119,837 | ||||||||||||
| Corporate debt securities | — | 53,161 | — | 53,161 | ||||||||||||
| Debt mutual funds | 7,030 | — | — | 7,030 | ||||||||||||
| U.S. government agency securities | — | 4,714 | — | 4,714 | ||||||||||||
| Certificates of deposit and time deposits | — | 1,312 | — | 1,312 | ||||||||||||
| Non-U.S. government securities | — | 578 | — | 578 | ||||||||||||
| Equity securities: | ||||||||||||||||
| Mutual funds | 42,033 | — | — | 42,033 | ||||||||||||
| $ | 769,955 | $ | 432,794 | $ | — | $ | 1,202,749 | |||||||||
| Derivative assets | — | 9 | — | 9 | ||||||||||||
| Total | $ | 769,955 | $ | 432,803 | $ | — | $ | 1,202,758 | ||||||||
| Liabilities | ||||||||||||||||
| Derivative liabilities | $ | — | $ | 469 | $ | — | $ | 469 | ||||||||
| Total | $ | — | $ | 469 | $ | — | $ | 469 | ||||||||
| Reported as follows: | ||||||||||||||||
| (Level 1) | (Level 2) | (Level 3) | Total | |||||||||||||
| (in thousands) | ||||||||||||||||
| Assets | ||||||||||||||||
| Cash and cash equivalents | $ | 720,892 | $ | 73,711 | $ | — | $ | 794,603 | ||||||||
| Marketable securities | — | 282,016 | — | 282,016 | ||||||||||||
| Long-term marketable securities | 49,063 | 77,067 | — | 126,130 | ||||||||||||
| Prepayments | — | 9 | — | 9 | ||||||||||||
| Total | $ | 769,955 | $ | 432,803 | $ | — | $ | 1,202,758 | ||||||||
| Liabilities | ||||||||||||||||
| Other current liabilities | $ | — | $ | 469 | $ | — | $ | 469 | ||||||||
| Total | $ | — | $ | 469 | $ | — | $ | 469 | ||||||||
| December 31, 2021 | ||||||||||||||||
| Quoted Prices in Active Markets for Identical Instruments (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | Total | |||||||||||||
| (in thousands) | ||||||||||||||||
| Assets | ||||||||||||||||
| Cash | $ | 628,740 | $ | — | $ | — | $ | 628,740 | ||||||||
| Cash equivalents | 412,212 | 81,247 | — | 493,459 | ||||||||||||
| Available for sale securities: | ||||||||||||||||
| Commercial paper | — | 189,620 | — | 189,620 | ||||||||||||
| U.S. Treasury securities | — | 77,789 | — | 77,789 | ||||||||||||
| Corporate debt securities | — | 56,901 | — | 56,901 | ||||||||||||
| Debt mutual funds | 7,971 | — | — | 7,971 | ||||||||||||
| U.S. government agency securities | — | 4,610 | — | 4,610 | ||||||||||||
| Certificates of deposit and time deposits | — | 1,356 | — | 1,356 | ||||||||||||
| Non-U.S. government securities | — | 589 | — | 589 | ||||||||||||
| Equity securities: | ||||||||||||||||
| Mutual funds | 39,253 | — | — | 39,253 | ||||||||||||
| Total | $ | 1,088,176 | $ | 412,112 | $ | — | $ | 1,500,288 | ||||||||
| Derivative assets | — | 92 | — | 92 | ||||||||||||
| Total | $ | 1,088,176 | $ | 412,204 | $ | — | $ | 1,500,380 | ||||||||
| Liabilities | ||||||||||||||||
| Derivative liabilities | $ | — | $ | 118 | $ | — | $ | 118 | ||||||||
| Total | $ | — | $ | 118 | $ | — | $ | 118 | ||||||||
| Reported as follows: | ||||||||||||||||
| (Level 1) | (Level 2) | (Level 3) | Total | |||||||||||||
| (in thousands) | ||||||||||||||||
| Assets | ||||||||||||||||
| Cash and cash equivalents | $ | 1,040,952 | $ | 81,247 | $ | — | $ | 1,122,199 | ||||||||
| Marketable securities | — | 244,231 | — | 244,231 | ||||||||||||
| Long-term marketable securities | 47,224 | 86,634 | — | 133,858 | ||||||||||||
| Prepayments | — | 92 | — | 92 | ||||||||||||
| Total | $ | 1,088,176 | $ | 412,204 | $ | — | $ | 1,500,380 | ||||||||
| Liabilities | ||||||||||||||||
| Other current liabilities | $ | — | $ | 118 | $ | — | $ | 118 | ||||||||
| Total | $ | — | $ | 118 | $ | — | $ | 118 | ||||||||
Changes in the fair value of Level 3 contingent consideration for the three months ended April 3, 2022, and April 4, 2021 were as follows:
| For the Three Months Ended | ||||||||
| April 3, 2022 | April 4, 2021 | |||||||
| (in thousands) | ||||||||
| Balance at beginning of period | $ | — | $ | 7,227 | ||||
| Fair value adjustment (a) | — | (7,227 | ) | |||||
| Balance at end of period | $ | — | $ | — | ||||
| (a) | In the three months ended April 4, 2021, the fair value of contingent consideration for the earn-outs in connection with the acquisition of AutoGuide was reduced to zero, which resulted in a benefit of $7.2 million, primarily due to a decrease in forecasted revenues and earnings before interest and taxes. |
|---|
On March 25, 2022, the arbitration claim filed by Industrial Automation LLC, sellers of AutoGuide, against Teradyne alleging
non-compliance
with the
earn-out
provisions of the Membership Interests Purchase Agreement (the “Purchase Agreement”), dated as of October 18, 2019, among Industrial Automation LLC, Teradyne and AutoGuide was settled
for
$26.7 million. As a result, Teradyne has no remaining
earn-out
obligations.
The carrying amounts and fair values of Teradyne’s financial instruments at April 3, 2022 and December 31, 2021 were as follows:
| April 3, 2022 | December 31, 2021 | |||||||||||||||
| Carrying Value | Fair Value | Carrying Value | Fair Value | |||||||||||||
| (in thousands) | ||||||||||||||||
| Assets | ||||||||||||||||
| Cash and cash equivalents | $ | 794,603 | $ | 794,603 | $ | 1,122,199 | $ | 1,122,199 | ||||||||
| Marketable securities | 408,146 | 408,146 | 378,089 | 378,089 | ||||||||||||
| Derivative assets | 9 | 9 | 92 | 92 | ||||||||||||
| Liabilities | ||||||||||||||||
| Derivative liabilities | 469 | 469 | 118 | 118 | ||||||||||||
| Convertible debt | 95,875 | 323,670 | 108,426 | 604,648 |
The fair values of accounts receivable, net and accounts payable approximate the carrying value due to the short-term nature of these instruments.
The following table summarizes the composition of
available-for-sale
marketable securities at April 3, 2022:
| April 3, 2022 | ||||||||||||||||||||
| Available-for-Sale | ||||||||||||||||||||
| Cost | Unrealized Gain | Unrealized (Loss) | Fair Market Value | Fair Market Value of Investments with Unrealized Losses | ||||||||||||||||
| (in thousands) | ||||||||||||||||||||
| Commercial paper | $ | 179,736 | $ | 3 | $ | (258 | ) | $ | 179,481 | $ | 106,951 | |||||||||
| U.S. Treasury securities | 121,504 | 8 | (1,675 | ) | 119,837 | 114,043 | ||||||||||||||
| Corporate debt securities | 53,079 | 1,585 | (1,503 | ) | 53,161 | 32,283 | ||||||||||||||
| Debt mutual funds | 7,150 | — | (120 | ) | 7,030 | — | ||||||||||||||
| U.S. government agency securities | 4,795 | — | (81 | ) | 4,714 | 4,714 | ||||||||||||||
| Certificates of deposit and time deposits | 1,312 | — | — | 1,312 | — | |||||||||||||||
| Non-U.S. government securities | 578 | — | — | 578 | — | |||||||||||||||
| $ | 368,154 | $ | 1,596 | $ | (3,637 | ) | $ | 366,113 | $ | 257,991 | ||||||||||
Reported as follows:
| Cost | Unrealized Gain | Unrealized (Loss) | Fair Market Value | Fair Market Value of Investments with Unrealized Losses | ||||||||||||||||
| (in thousands) | ||||||||||||||||||||
| Marketable securities | $ | 282,563 | $ | 11 | $ | (558 | ) | $ | 282,016 | $ | 202,243 | |||||||||
| Long-term marketable securities | 85,591 | 1,585 | (3,079 | ) | 84,097 | 55,748 | ||||||||||||||
| $ | 368,154 | $ | 1,596 | $ | (3,637 | ) | $ | 366,113 | $ | 257,991 | ||||||||||
The following table summarizes the composition of
available-for-sale
marketable securities at December 31, 2021:
| December 31, 2021 | ||||||||||||||||||||
| Available-for-Sale | ||||||||||||||||||||
| Cost | Unrealized Gain | Unrealized (Loss) | Fair Market Value | Fair Market Value of Investments with Unrealized Losses | ||||||||||||||||
| (in thousands) | ||||||||||||||||||||
| Commercial paper | $ | 189,614 | $ | 15 | $ | (9 | ) | $ | 189,620 | $ | 22,784 | |||||||||
| U.S. Treasury securities | 77,707 | 551 | (470 | ) | 77,789 | 46,435 | ||||||||||||||
| Corporate debt securities | 52,266 | 4,863 | (227 | ) | 56,901 | 19,422 | ||||||||||||||
| Debt mutual funds | 7,928 | 43 | — | 7,971 | — | |||||||||||||||
| U.S. government agency securities | 4,617 | 5 | (12 | ) | 4,610 | 3,296 | ||||||||||||||
| Certificates of deposit and time deposits | 1,356 | — | — | 1,356 | — | |||||||||||||||
| Non-U.S. government securities | 589 | — | — | 589 | — | |||||||||||||||
| $ | 334,077 | $ | 5,477 | $ | (718 | ) | $ | 338,836 | $ | 91,937 | ||||||||||
Reported as follows:
| Cost | Unrealized Gain | Unrealized (Loss) | Fair Market Value | Fair Market Value of Investments with Unrealized Losses | ||||||||||||||||
| (in thousands) | ||||||||||||||||||||
| Marketable securities | $ | 244,213 | $ | 64 | $ | (46 | ) | $ | 244,231 | $ | 54,798 | |||||||||
| Long-term marketable securities | 89,864 | 5,413 | (672 | ) | 94,605 | 37,139 | ||||||||||||||
| $ | 334,077 | $ | 5,477 | $ | (718 | ) | $ | 338,836 | $ | 91,937 | ||||||||||
As of April 3, 2022, the fair market value of investments with unrealized losses less than one year and greater than one year totaled $248.2 million and $9.8 million
,
respectively. As of December 31, 2021, the fair market value of investments with unrealized losses for less than one year and greater than one year totaled $85.4 million and $6.5 million, respectively.
Teradyne reviews its investments to identify and evaluate investments that have an indication of possible impairment. Based on this review, Teradyne determined that the unrealized losses related to these investments at April 3, 2022 and December 31, 2021 were not other than temporary.
The contractual maturities of investments in
available-for-sale
securities held at April 3, 2022 were as follows:
| April 3, 2022 | ||||||||
| Cost | Fair Market Value | |||||||
| (in thousands) | ||||||||
| Due within one year | $ | 282,563 | $ | 282,016 | ||||
| Due after 1 year through 5 years | 36,844 | 35,718 | ||||||
| Due after 5 years through 10 years | 6,117 | 5,978 | ||||||
| Due after 10 years | 35,480 | 35,371 | ||||||
| Total | $ | 361,004 | $ | 359,083 | ||||
Contractual maturities of investments in
available-for-sale
securities held at April 3
, 2022
exclude debt mutual funds with a fair market value of $7.0 million, as they do not have a contractual maturity date.
Derivatives
Teradyne conducts business in a number of foreign countries, with certain transactions denominated in local currencies. The purpose of Teradyne’s foreign currency management is to minimize the effect of exchange rate fluctuations on certain foreign currency denominated monetary assets and liabilities. Teradyne does not use derivative financial instruments for trading or speculative purposes.
To minimize the effect of exchange rate fluctuations associated with the remeasurement of monetary assets and liabilities denominated in foreign currencies, Teradyne enters into foreign currency forward contracts. The change in fair value of these derivatives is recorded directly in earnings and is used to offset the change in value of monetary assets and liabilities denominated in foreign currencies.
At April 3, 2022 and December 31, 2021, Teradyne had the following contracts to buy and sell non-U.S. currencies for U.S. dollars and other non-U.S. currencies with the following notional amounts:
| April 3, 2022 | December 31, 2021 | |||||||||||||||||||||||
| Buy Position | Sell Position | Net Total | Buy Position | Sell Position | Net Total | |||||||||||||||||||
| (in millions) | ||||||||||||||||||||||||
| Japanese Yen | $ | (45.9 | ) | $ | — | $ | (45.9 | ) | $ | (31.4 | ) | $ | — | $ | (31.4 | ) | ||||||||
| Taiwan Dollar | (43.7 | ) | — | (43.7 | ) | (35.1 | ) | — | (35.1 | ) | ||||||||||||||
| Korean Won | (5.0 | ) | — | (5.0 | ) | (4.2 | ) | — | (4.2 | ) | ||||||||||||||
| British Pound Sterling | (2.9 | ) | — | (2.9 | ) | (1.8 | ) | — | (1.8 | ) | ||||||||||||||
| Singapore Dollar | — | 75.5 | 75.5 | — | 61.9 | 61.9 | ||||||||||||||||||
| Euro | — | 42.3 | 42.3 | — | 44.9 | 44.9 | ||||||||||||||||||
| Philippine Peso | — | 3.8 | 3.8 | — | 3.9 | 3.9 | ||||||||||||||||||
| Chinese Yuan | — | 2.8 | 2.8 | — | 2.8 | 2.8 | ||||||||||||||||||
| Total | $ | (97.5 | ) | $ | 124.4 | $ | 26.9 | $ | (72.5 | ) | $ | 113.5 | $ | 41.0 | ||||||||||
The fair value of the outstanding contracts was a loss of $0.5 million and $0.1 million, respectively, at April 3, 2022 and December 31, 2021.
Gains and losses on foreign currency forward contracts and foreign currency remeasurement gains and losses on monetary assets and liabilities are included in other (income) expense, net.
The following table summarizes the fair value of derivative instruments as of April 3, 2022 and December 31,
2021:
| Balance Sheet Location | April 3, 2022 | December 31, 2021 | ||||||||
| (in thousands) | ||||||||||
| Derivatives not designated as hedging instruments: | ||||||||||
| Foreign exchange contracts | Prepayments | $ | 9 | $ | 92 | |||||
| Foreign exchange contracts | Other current liabilities | (469 | ) | (118 | ) | |||||
| Total derivatives | $ | (460 | ) | $ | (26 | ) | ||||
The following table summarizes the effect of derivative instruments recognized in the statement of operations for the three months ended April 3, 2022 and April 4, 2021:
| Location of (Gains) Losses | For the Three Months Ended | |||||||||||
| Recognized in Statement of Operations | April 3, 2022 | April 4, 2021 | ||||||||||
| (in thousands) | ||||||||||||
| Derivatives not designated as hedging instruments: | ||||||||||||
| Foreign exchange contracts | Other (income) expense, net | $ | (1,752 | ) | $ | 2,118 |
| (1) | The table does not reflect the corresponding gains and losses from the remeasurement of the monetary assets and liabilities denominated in foreign currencies. |
|---|
| (2) | For the three months ended April 3, 2022 , net losses from the remeasurement of monetary assets and liabilities denominated in foreign currencies were $4.3 million. |
|---|
| (3) | For the three months ended April 4, 2021, net gains from the remeasurement of monetary assets and liabilities denominated in foreign currencies were $0.2 million. |
|---|
See Note H: “Debt” regarding derivatives related to the convertible senior notes.
H. DEBT
Convertible Senior Notes
On December 12,
2016
, Teradyne completed a private offering of $460.0 million aggregate principal amount of 1.25% convertible senior unsecured notes (the “Notes”) due
December 15, 2023
and received net proceeds, after issuance costs, of approximately $450.8 million, $33.0 million of which was used to pay the net cost of the convertible note hedge transactions and $50.1 million of which was used to repurchase 2.0 million shares of Teradyne’s
common stock under its existing stock repurchase
program
from purchasers of the Notes in privately negotiated transactions effected through one of the initial purchasers or its affiliates conducted concurrently with the pricing of the Note offering. The Notes will mature on December 15, 2023, unless earlier repurchased or converted. The Notes bear interest at a rate of
1.25
% per year
payable semiannually in arrears on June 15 and December 15 of each year
. The Notes will be convertible at the option of the noteholders at any time prior to the close of business on the business day immediately preceding September 15, 2023, only under the following circumstances: (1) during any calendar quarter beginning after
March 31, 2017
(and only during such calendar quarter), if the closing sale price of Teradyne’s common stock, for at least
trading days (whether or not consecutive) during a period of
consecutive trading days ending on the last trading day of the immediately preceding
calendar
quarter is greater than
% of the conversion price on each applicable trading day; (2) during the
five
business day period after any
five
consecutive trading day period (the “measurement period”) in which the trading price (as defined in the Indenture) per $
1,000
principal amount of Notes for each trading day of the measurement period was less than
% of the product of the closing sale price of the Teradyne’s common stock and the conversion rate on each such trading day; and (3) upon the occurrence of specified corporate events. On or after
September 15, 2023
until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their Notes at any time, regardless of the foregoing circumstances. Teradyne may satisfy its future conversion obligation by paying cash for the principal amount of the Notes and paying or delivering cash, shares of its common stock or a combination of cash and shares of its common stock, at Teradyne’s election for the amount in excess of principal. As of April 3, 2022, the conversion price was approximately $
31.51
per share of Teradyne’s common stock. The conversion rate is subject to adjustment under certain circumstances. As of May 6, 2022, ninety
eight holders had exercised the option to convert $
373.5
million worth of notes.
Concurrent with the offering of the Notes, Teradyne entered into convertible note hedge transactions (the “Note Hedge Transactions”) with the initial purchasers or their affiliates (the “Option Counterparties”). The Note Hedge Transactions cover, subject to customary anti-dilution adjustments, the number of shares of the common stock that underlie the Notes, with a strike price equal to the conversion price of the Notes of $31.51.
Separately and concurrent with the pricing of the Notes, Teradyne entered into warrant transactions with the Option Counterparties (the “Warrant Transactions”) in which it sold
net-share-settled
(or, at its election subject to certain conditions, cash-settled) warrants to the Option Counterparties. The Warrant Transactions currently cover, subject to customary anti-dilution adjustments, approximately 14.6 million shares of common stock. As of April 3, 2022, the strike price of the warrants was approximately $39.54 per share. The strike price is subject to adjustment under certain circumstances. The Warrant Transactions could have a dilutive effect to Teradyne’s common stock to the extent that the market price per share of Teradyne’s common stock, as measured under the terms of the Warrant Transactions, exceeds the applicable strike price of the warrants.
The Note Hedge Transactions are expected to reduce the potential dilution to Teradyne’s common stock upon any conversion of the Notes. However, the Warrant Transactions could separately have a dilutive effect to the extent that the market value per share of Teradyne’s common stock exceeds the applicable strike price of the warrant. The net cost of the Note Hedge Transactions, after being partially offset by the proceeds from the sale of the warrants, was approximately $33.0 million.
In connection with establishing their initial hedge of these convertible note hedge and warrant transactions, the Option Counterparties have entered into various derivative transactions with respect to Teradyne’s common stock and/or purchased shares of Teradyne’s common stock or other securities, including the Notes, concurrent with, or shortly after, the pricing of the Notes. In addition, the Option Counterparties may modify their hedge positions by entering into or unwinding various derivative transactions with respect to Teradyne’s common stock or by selling Teradyne’s common stock or other securities, including the Notes, in secondary market transactions (and may do so during any observation period related to the conversion of the Notes). These activities could adversely affect the value of Teradyne’s common stock and the Notes.
Originally, Teradyne
allocated $100.8 million of the $460.0 million principal amount of the Notes to the equity component, which represent
ed
a discount to the debt and
was
amortized to interest expense using the effective interest method through December 2023.
Effective January 1, 2022, Teradyne adopted ASC 2020-06 using the modified retrospective method of transition and accounts for the debt as a single liability measured at its amortized cost. As a result of the adoption, Teradyne recorded an increase of
$1.4
million to current debt for unsettled shares, an increase of
$6.6 million
to long-term debt for unamortized debt discount, and an increase to retained earnings of
$92.8 million
for the reclassification of the equity component. Mezzanine equity representing unsettled shares value was reduced to zero and additional paid-in capital was reduced by
$99.3 million.
On November 4, 2021, Teradyne made an irrevocable election under the Indenture to require the principal portion of the remaining Notes to be settled in cash.
Debt issuance
fees
of approximately $0.4 million
, at April 3, 2022,
are being amortized to interest expense using the effective interest method over the seven-year term of the Notes.
The below tables represent the key components of Teradyne’s convertible senior notes:
| April 3, 2022 | December 31, 2021 | |||||||
| (in thousands) | ||||||||
| Debt principal | $ | 96,285 | $ | 116,980 | ||||
| Unamortized debt issuance fees (1) | 410 | 8,554 | ||||||
| Net carrying amount of convertible debt | $ | 95,875 | $ | 108,426 | ||||
Reported as follows:
| April 3, 2022 | December 31, 2021 | |||||||
| (in thousands) | ||||||||
| Current debt | $ | 20,497 | $ | 19,182 | ||||
| Long-term debt | 75,378 | 89,244 | ||||||
| Net carrying amount of convertible debt | $ | 95,875 | $ | 108,426 | ||||
| For the Three Months Ended | ||||||||
| April 3, 2022 | April 4, 2021 | |||||||
| (in thousands) | ||||||||
| Contractual interest expense on the coupon | $ | 311 | $ | 1,239 | ||||
| Amortization of debt issuance fees recognized as interest expense ( 2 ) | 66 | 3,836 | ||||||
| Total interest expense on the convertible debt | $ | 377 | $ | 5,075 | ||||
| (1) | Unamortized debt issuance fees as of December 31, 2021 include unamortized debt discount of $8.1 million, which was eliminated with the adoption of ASU 2020-6 on January 1, 2022. |
|---|
| (2) | Three months ended April 4, 2021 includes the amortization of debt discount component, which was eliminated with the adoption of ASU 2020-06 on January 1, 2022. |
|---|
As of April 3, 2022, the conversion price was approximately $31.51 per share and the
if-converted
value of the notes was $355.6 million.
During the three months ended April 3, 2022, eleven debt holders elected to convert $20.7 million of debt principal. The conversion of the debt was settled in cash for principal amount and in shares for the excess of conversion value over principal amount. The 0.5 million shares issued to the debt holders were received from exercising the convertible notes hedge call options.
Additional conversions of approximately $20.5 million of debt principal will occur in the second quarter of 2022 and the liability is included in current debt.
Teradyne expects to make principal interest payments of $1.2 million in the next 12 months and $1.2 million thereafter.
Revolving Credit Facility
On May 1, 2020, Teradyne entered into a credit agreement (the “Credit Agreement”) with Truist Bank, as administrative agent and collateral agent, and the lenders party thereto. The Credit Agreement provide
d
for a three-year, senior secured revolving credit facility of $400.0 million (the “Credit Facility”).
On December 10, 2021, the Credit Agreement was amended to extend maturity date of the Credit Facility to December 10, 2026. The amended Credit Agreement provides that, subject to customary conditions, Teradyne may seek to obtain from existing or new lenders the available incremental amount under the Credit Facility, not to exceed the greater of $200.0 million or 15% of consolidated EBIDTA. The interest rate applicable to loans under the Credit Facility are, at Teradyne’s option, equal to either a base rate plus a margin ranging from 0.00% to 0.75% per annum or LIBOR plus a margin ranging from 1.00% to 1.75% per annum, based on the consolidated leverage ratio of Teradyne. In addition, Teradyne will pay a commitment fee on the unused portion of the commitments under the Credit Facility ranging from 0.15% to 0.25% per annum, based on the then applicable consolidated leverage ratio.
Teradyne is not required to repay any loans under the Credit Facility prior to maturity, subject to certain customary exceptions. Teradyne is permitted to prepay all or any portion of the loans under the Credit Facility prior to maturity without premium or penalty, other than customary LIBOR breakage costs.
The Credit Agreement contains customary events of default, representations, warranties and affirmative and negative covenants that, among other things, limit Teradyne’s ability to sell assets, grant liens on assets, incur other secured indebtedness and make certain investments and restricted payments, all subject to exceptions set forth in the Credit Agreement. The Credit Agreement also requires Teradyne to satisfy two financial ratios measured as of the end of each fiscal quarter a consolidated leverage ratio and an interest coverage ratio.
The Credit Facility is guaranteed by certain of Teradyne’s domestic subsidiaries and collateralized by assets of Teradyne and such subsidiaries, including a pledge of 65% of the capital stock of certain foreign subsidiaries.
As of May 6, 2022, Teradyne has not borrowed any funds under the credit facility and was in compliance with all covenants.
I. PREPAYMENTS
Prepayments consist of the following:
| April 3, 2022 | December 31, 2021 | |||||||
| (in thousands) | ||||||||
| Contract manufacturer and supplier prepayments | $ | 441,665 | $ | 364,478 | ||||
| Prepaid maintenance and other services | 14,772 | 13,660 | ||||||
| Prepaid taxes | 10,756 | 15,090 | ||||||
| Other prepayments | 12,221 | 13,038 | ||||||
| Total prepayments | $ | 479,414 | $ | 406,266 | ||||
J. PRODUCT WARRANTY
Teradyne generally provides a
one-year
warranty on its products, commencing upon installation, acceptance or shipment. A provision is recorded upon revenue recognition to cost of revenues for estimated warranty expense based on historical experience. Related costs are charged to the warranty accrual as incurred. The balance below is included in other accrued liabilities.
| For the Three Months Ended | ||||||||
| April 3, 2022 | April 4, 2021 | |||||||
| (in thousands) | ||||||||
| Balance at beginning of period | $ | 24,577 | $ | 16,633 | ||||
| Accruals for warranties issued during the period | 4,100 | 11,881 | ||||||
| Accruals related to pre-existing warranties | (2,758 | ) | 447 | |||||
| Settlements made during the period | (5,814 | ) | (5,068 | ) | ||||
| Balance at end of period | $ | 20,105 | $ | 23,893 | ||||
When Teradyne receives revenue for extended warranties, beyond one year, it is deferred and recognized on a straight-line basis over the contract period. Related costs are expensed as incurred. The balance below is included in short and long-term deferred revenue and customer advances.
| For the Three Months Ended | ||||||||
| April 3, 2022 | April 4, 2021 | |||||||
| (in thousands) | ||||||||
| Balance at beginning of period | $ | 64,168 | $ | 51,929 | ||||
| Deferral of new extended warranty revenue | 11,774 | 7,517 | ||||||
| Recognition of extended warranty deferred revenue | (10,216 | ) | (5,538 | ) | ||||
| Balance at end of period | $ | 65,726 | $ | 53,908 | ||||
K. STOCK-BASED COMPENSATION
Under Teradyne’s stock compensation plans, Teradyne grants service-based restricted stock units, performance-based restricted stock units and stock options, and employees are eligible to purchase Teradyne’s common stock through its Employee Stock Purchase Plan (“ESPP”).
Service-based restricted stock unit awards granted to employees vest in equal annual installments over four years. Restricted stock unit awards granted to
non-employee
directors vest after a
one-year
period, with 100% of the award vesting on the earlier of (a) the first anniversary of the grant date or (b) the date of the following year’s Annual Meeting of Shareholders. Teradyne expenses the cost of the restricted stock unit awards subject to service-based vesting, which is determined to be the fair market value of the shares at the date of grant, ratably over the period during which the restrictions lapse.
Performance-based restricted stock units (“PRSUs”) granted to Teradyne’s executive officers may have a performance metric based on relative total shareholder return (“TSR”). Teradyne’s three-year TSR performance is measured against the New York Stock Exchange (“NYSE”) Composite Index. The final number of TSR PRSUs that vest will vary based upon the level of performance achieved from 0% to 200% of the target shares. The TSR PRSUs will vest upon the three-year anniversary of the grant date. The TSR PRSUs are valued using a Monte Carlo simulation model. The number of units expected to be earned, based upon the achievement of the TSR market condition, is factored into the grant date Monte Carlo valuation. Compensation expense is recognized on a straight-line basis over the shorter of the three-year service period or the period from the grant to the date described in the retirement provisions below. Compensation expense for executive officers meeting the retirement provisions prior to the grant date is recognized during the year following the grant. Compensation expense is recognized regardless of the eventual number of units that are earned based upon the market condition, provided the executive officer remains an employee at the end of the three-year period. Compensation expense is reversed if at any time during the three-year service period the executive officer is no longer an employee, subject to the retirement and termination eligibility provisions noted below.
PRSUs granted to Teradyne’s executive officers may also have a performance metric based on three-year cumulative
non-GAAP
profit before interest and tax (“PBIT”) as a percent of Teradyne’s revenue.
Non-GAAP
PBIT is a financial measure equal to GAAP income from operations less restructuring and other, amortization of acquired intangible assets; acquisition and divestiture related charges or credits; pension actuarial gains and losses; and other
non-recurring
gains and charges. The final number of PBIT PRSUs that vest will vary based upon the level of performance achieved from 0% to 200% of the target shares. The PBIT PRSUs will vest upon the three-year anniversary of the grant date. Compensation expense is recognized on a straight-line basis over the shorter of the three-year service period or the period from the grant date to the date described in the retirement provisions below. Compensation expense for executive officers meeting the retirement provisions prior to the grant date is recognized during the year following the grant. Compensation expense is recognized based on the number of units that are earned based upon the three-year Teradyne PBIT as a percent of Teradyne’s revenue, provided the executive officer remains an employee at the end of the three-year period subject to the
retirement and termination eligibility provisions noted below.
If
a PRSU recipient’s employment ends prior to the determination of the performance percentage due to (1) permanent disability or death or (2) retirement or termination other than for cause, after attaining both at least age sixty and at least ten years of service, then all or a portion of the recipient’s PRSUs (based on the actual performance percentage achieved on the determination date) will vest on the date the performance percentage is determined. Except as set forth in the preceding sentence, no PRSUs will vest if the executive officer is no longer an employee at the end of the three-year period.
Stock options to purchase Teradyne’s common stock at 100% of the fair market value on the grant date vest in equal annual installments over four years from the grant date and have a maximum term of seven years.
During
the three months ended April
,
2022
and April
,
2021
, Teradyne granted
0.4
million and
0.3
million of service-based restricted stock unit awards to employees at a weighted average grant date fair value of $
111.31
and $
112.55
, respectively.
During the three months ended April 3, 2022 and April 4, 2021, Teradyne granted 0.1 million of PBIT PRSUs with a grant date fair value of $110.84 and $112.28, respectively.
During the three months ended April 3, 2022 and April 4, 2021, Teradyne granted 0.1 million of TSR PRSUs, with a grant date fair value of $101.06 and $125.02, respectively. The fair value was estimated using the Monte Carlo simulation model with the following assumptions:
| For the Three Months Ended | ||||||||
| April 3, 2022 | April 4, 2021 | |||||||
| Risk-free interest rate | 1.4 | % | 0.2 | % | ||||
| Teradyne volatility-historical | 47.1 | % | 43.9 | % | ||||
| NYSE Composite Index volatility-historical | 22.7 | % | 22.9 | % | ||||
| Dividend yield | 0.4 | % | 0.4 | % |
Expected
volatility was based on the historical volatility of Teradyne’s stock and the NYSE Composite Index over the most recent three-year period. The risk-free interest rate was determined using the U.S. Treasury yield curve in effect at the time of grant. Dividend yield was based upon an estimated annual dividend amount of $
0.44
per share divided by Teradyne’s stock price on the grant date of $
112.12
for the 2022 grant and an estimated annual dividend amount of $
0.40
per share divided by Teradyne’s stock price on the grant date of $
113.48
for the 2021 grant.
During the three months ended April 3, 2022 and April 4, 2021, Teradyne granted 0.1 million of service-based stock options to executive officers at a weighted average grant date fair value of $39.01 and $36.60, respectively.
The fair value of stock options was estimated using the Black-Scholes option-pricing model with the following assumptions:
| For the Three Months Ended | ||||||||
| April 3, 2022 | April 4, 2021 | |||||||
| Expected life (years) | 4.0 | 5.0 | ||||||
| Risk-free interest rate | 1.6 | % | 0.4 | % | ||||
| Volatility-historical | 43.7 | % | 37.8 | % | ||||
| Dividend yield | 0.4 | % | 0.4 | % |
Teradyne determined the stock options’ expected life based upon historical exercise data for executive officers, the age of the executive officers and the terms of the stock option grant. Volatility was determined using historical volatility for a period equal to the expected life. The risk-free interest rate was determined using the U.S. Treasury yield curve in effect at the time of grant. Dividend yield was based upon an estimated annual dividend amount of $0.44 per share divided by Teradyne’s stock price on the grant date of $112.12 for the 2022 grant and an estimated annual dividend amount of $0.40 per share divided by Teradyne’s stock price on the grant date of $113.48 for the 2021 grant.
L. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
Changes in accumulated other comprehensive income (loss), which are presented net of tax, consist of the following:
| Foreign Currency Translation Adjustment | Unrealized Gains (Losses) on Marketable Securities | Retirement Plans Prior Service Credit | Total | |||||||||||||
| (in thousands) | ||||||||||||||||
| Three Months Ended April 3, 2022 | ||||||||||||||||
| Balance at December 31, 2021, net of tax of $0, $1,055, $(1,128), respectively | $ | (10,818 | ) | $ | 3,704 | $ | 1,166 | $ | (5,948 | ) | ||||||
| Other comprehensive loss before reclassifications, net of tax of $0, $(1,333), $0, respectively | (8,076 | ) | (5,388 | ) | — | (13,464 | ) | |||||||||
| Amounts reclassified from accumulated other comprehensive income, net of tax of $0, $(18), $0, respectively | — | (65 | ) | (2 | ) | (67 | ) | |||||||||
| Net current period other comprehensive loss, net of tax of $0, $(1,351), $0, respectively | (8,076 | ) | (5,453 | ) | (2 | ) | (13,531 | ) | ||||||||
| Balance at April 3, 2022, net of tax of $0, $(296), $(1,128), respectively | $ | (18,894 | ) | $ | (1,749 | ) | $ | 1,164 | $ | (19,479 | ) | |||||
| Three Months Ended April 4, 2021 | ||||||||||||||||
| Balance at December 31, 2020, net of tax of $0, $1,910, $(1,126), respectively | $ | 25,389 | $ | 6,954 | $ | 1,173 | $ | 33,516 | ||||||||
| Other comprehensive loss before reclassifications, net of tax of $0, $(908), $0, respectively | (21,123 | ) | (3,270 | ) | — | (24,393 | ) | |||||||||
| Amounts reclassified from accumulated other comprehensive income, net of tax of $0, $(123), $0, respectively | — | (444 | ) | (2 | ) | (446 | ) | |||||||||
| Net current period other comprehensive loss, net of tax of $0, $(1,031), $0, respectively | (21,123 | ) | (3,714 | ) | (2 | ) | (24,839 | ) | ||||||||
| Balance at April 4, 2021, net of tax of $0, $879, $(1,126), respectively | $ | 4,266 | $ | 3,240 | $ | 1,171 | $ | 8,677 | ||||||||
Reclassifications out of accumulated other comprehensive income (loss) to the statement of operations for the three months ended April 3, 2022 and April 4, 2021 were as follows:
| Details about Accumulated Other Comprehensive Income (Loss) Components | For the Three Months Ended | Affected Line Item in the Statements of Operations | ||||||||||
| April 3, | April 4, | |||||||||||
| 2022 | 2021 | |||||||||||
| (in thousands) | ||||||||||||
| Available-for-sale marketable securities: | ||||||||||||
| Unrealized gains, net of tax of $18 and $123, respectively | $ | 65 | $ | 444 | Other (income) expense, net | |||||||
| Defined benefit pension and postretirement plans: | ||||||||||||
| Amortization of prior service cre dit , net of tax of $0 and $0, respectively | 2 | 2 | (a) | |||||||||
| Total reclassifications, net of tax of $18 and $123, respectively | $ | 67 | $ | 446 | Net income | |||||||
| (a) | The amortization of prior service credit is included in the computation of net periodic postretirement benefit cost. See Note P : “Retirement Plans.” |
|---|
M. GOODWILL AND ACQUIRED INTANGIBLE ASSETS
Goodwill
Teradyne performs its annual goodwill impairment test as required under the provisions of ASC
350-10,
“Intangibles—Goodwill and Other”
on December 31 of each fiscal year unless interim indicators of impairment exist. In the three months ended April 3, 2022
,
there were no interim indicators of impairment. Goodwill is considered impaired when the net book value of a reporting unit exceeds its estimated fair value.
The changes in the carrying amount of goodwill by reportable segments for the three months ended April 3, 2022, were as follows:
| Industrial Automation | Wireless Test | Semiconductor Test | System Test | Total | ||||||||||||||||
| (in thousands) | ||||||||||||||||||||
| Balance at December 31, 2021 | ||||||||||||||||||||
| Goodwill | $ | 405,971 | $ | 361,819 | $ | 262,101 | $ | 158,699 | $ | 1,188,590 | ||||||||||
| Accumulated impairment losses | — | (353,843 | ) | (260,540 | ) | (148,183 | ) | (762,566 | ) | |||||||||||
| Total goodwill | 405,971 | 7,976 | 1,561 | 10,516 | 426,024 | |||||||||||||||
| Foreign currency translation adjustment | (6,122 | ) | — | (14 | ) | — | (6,136 | ) | ||||||||||||
| Balance at April 3, 2022 | ||||||||||||||||||||
| Goodwill | 399,849 | 361,819 | 262,087 | 158,699 | 1,182,454 | |||||||||||||||
| Accumulated impairment losses | — | (353,843 | ) | (260,540 | ) | (148,183 | ) | (762,566 | ) | |||||||||||
| Total goodwill | $ | 399,849 | $ | 7,976 | $ | 1,547 | $ | 10,516 | $ | 419,888 | ||||||||||
Intangible Assets
Teradyne reviews long-lived assets for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable or that the useful lives of these assets are no longer appropriate.
Amortizable intangible assets consist of the following and are included in intangible assets, net on the balance sheet:
| Gross Carrying Amount | Accumulated Amortization | Foreign Currency Translation Adjustment | Net Carrying Amount | |||||||||||||
| (in thousands) | ||||||||||||||||
| Balance at April 3, 2022 | ||||||||||||||||
| Developed technology | $ | 272,547 | $ | (226,648 | ) | $ | (4,565 | ) | $ | 41,334 | ||||||
| Customer relationships | 57,739 | (49,492 | ) | 194 | 8,441 | |||||||||||
| Tradenames and trademarks | 59,387 | (38,494 | ) | (822 | ) | 20,071 | ||||||||||
| Total intangible assets | $ | 389,673 | $ | (314,634 | ) | $ | (5,193 | ) | $ | 69,846 | ||||||
| Balance, December 31, 2021 | ||||||||||||||||
| Developed technology | $ | 272,547 | $ | (223,413 | ) | $ | (4,093 | ) | $ | 45,041 | ||||||
| Customer relationships | 57,739 | (48,921 | ) | 209 | 9,027 | |||||||||||
| Tradenames and trademarks | 59,387 | (37,237 | ) | (583 | ) | 21,567 | ||||||||||
| Total intangible assets | $ | 389,673 | $ | (309,571 | ) | $ | (4,467 | ) | $ | 75,635 | ||||||
Aggregate
intangible asset amortization expense for the three months ended April 3, 2022 and April 4, 2021 was $
5.1
million and $
5.5
million, respectively.
Estimated intangible asset amortization expense for each of the five succeeding fiscal years
and thereafter
is as follows:
| Year | Amortization Expense | |||
| (in thousands) | ||||
| 2022 | $ | 14,879 | ||
| 2023 | 19,377 | |||
| 2024 | 19,069 | |||
| 2025 | 11,456 | |||
| 2026 | 2,404 | |||
| Thereafter | 2,661 |
N. NET INCOME PER COMMON SHARE
The following table sets forth the computation of basic and diluted net income per common share:
| For the Three Months Ended | ||||||||
| April 3, | April 4, | |||||||
| 2022 | 2021 | |||||||
| (in thousands, except per share amounts) | ||||||||
| Net income for basic and diluted net income per share | $ | 161,928 | $ | 205,512 | ||||
| Weighted average common shares-basic | 162,048 | 166,491 | ||||||
| Effect of dilutive potential common shares: | ||||||||
| Convertible note hedge warrant shares (1) | 10,028 | 9,429 | ||||||
| Incremental shares from assumed conversion of convertible notes (2) | 2,541 | 10,310 | ||||||
| Restricted stock units | 875 | 1,395 | ||||||
| Stock options | 69 | 108 | ||||||
| Employee stock purchase plan | 14 | 7 | ||||||
| Dilutive potential common shares | 13,527 | 21,249 | ||||||
| Weighted average common shares-diluted | 175,575 | 187,740 | ||||||
| Net income per common share-basic | $ | 1.00 | $ | 1.23 | ||||
| Net income per common share-diluted | $ | 0.92 | $ | 1.09 | ||||
| (1) | Convertible notes hedge warrant shares were calculated using the difference between the average Teradyne stock price for the period and the warrant price of $39.54, multiplied by 14.6 million shares. The result of this calculation, representing the total intrinsic value of the warrant, was divided by the average Teradyne stock price for the period. |
|---|
| (2) | Incremental shares from assumed conversion of the convertible notes were calculated using the difference between the average Teradyne stock price for the period and the conversion price of $31.51, multiplied by 3.4 million shares. The result of this calculation, representing the total intrinsic value of the convertible debt, was divided by the average Teradyne stock price for the period. |
|---|
The computation of diluted net income per common share for the three months ended April 3, 2022 and April 4, 2021 excludes the effect of the potential vesting of 0.1 million and 0.1 million, respectively, of restricted stock units because the effect would have been anti-dilutive.
O. RESTRUCTURING AND OTHER
During the three months ended April 3, 2022, Teradyne recorded a charge of $14.7
million related to the arbitration claim filed against Teradyne and AutoGuide related to an earn-out dispute, which was settled
on
March
25,
2022 for $26.7 million. Previously, in the three months ended December 31, 2021, Teradyne recorded a charge of $12.0 million related to this earn-out dispute.
During the three months ended April 4, 2021, Teradyne recorded a gain of $7.2
million for the decrease in the fair value of the AutoGuide contingent consideration liability.
P. RETIREMENT PLANS
ASC 715, “Compensation—Retirement Benefits,” requires an employer with defined benefit plans or other postretirement benefit plans to recognize an asset or a liability on its balance sheet for the overfunded or underfunded status of the plans as defined by ASC 715. The pension asset or liability represents a difference between the fair value of the pension plan’s assets and the projected benefit obligation at December 31. Teradyne uses a December 31 measurement date for all of its plans.
Defined Benefit Pension Plans
Teradyne has defined benefit pension plans covering a portion of domestic employees and employees of certain
non-U.S.
subsidiaries. Benefits under these plans are based on employees’ years of service and compensation. Teradyne’s funding policy is to make contributions to these plans in accordance with local laws and to the extent that such contributions are tax deductible. The assets of the U.S. qualified pension plan consist primarily of fixed income and equity securities. In addition, Teradyne has an unfunded supplemental executive defined benefit plan in the United States to provide retirement benefits in excess of levels allowed by the Employment Retirement Income Security Act (“ERISA”) and the Internal Revenue Code (the “IRC”), as well as unfunded qualified foreign plans.
In the
three
months ended April
,
2022
and April
,
2021
, Teradyne contributed $
0.8
million and $
0.8
million, respectively, to the U.S. supplemental executive defined benefit pension plan
,
and $
0.3
million and $
0.3
million, respectively, to certain qualified pension plans for
non-U.S.
subsidiaries.
For the three months ended April 3, 2022 and April 4, 2021, Teradyne’s net periodic pension cost was comprised of the following:
| For the Three Months Ended | ||||||||||||||||
| April 3, 2022 | April 4, 2021 | |||||||||||||||
| United States | Foreign | United States | Foreign | |||||||||||||
| (in thousands) | ||||||||||||||||
| Service cost | $ | 397 | $ | 206 | $ | 453 | $ | 243 | ||||||||
| Interest cost | 1,222 | 118 | 1,100 | 87 | ||||||||||||
| Expected return on plan assets | (732 | ) | (20 | ) | (936 | ) | (16 | ) | ||||||||
| Total net periodic pension cost | $ | 887 | $ | 304 | $ | 617 | $ | 314 | ||||||||
Postretirement Benefit Plan
In addition to receiving pension benefits, Teradyne employees in the United States who meet early retirement eligibility requirements as of their termination dates may participate in Teradyne’s Welfare Plan, which includes medical and dental benefits up to age 65. Death benefits provide a fixed sum to retirees’ survivors and are available to all retirees. Substantially all of Teradyne’s current U.S. employees could become eligible for these benefits, and the existing benefit obligation relates primarily to those employees.
For the three months ended April 3, 2022 and April 4, 2021, Teradyne’s net periodic postretirement benefit cost was comprised of the following:
| For the Three Months Ended | ||||||||
| April 3, 2022 | April 4, 2021 | |||||||
| (in thousands) | ||||||||
| Service cost | $ | 17 | $ | 16 | ||||
| Interest cost | 44 | 44 | ||||||
| Amortization of prior service credit | (2 | ) | (2 | ) | ||||
| Total net periodic postretirement benefit cost | $ | 59 | $ | 58 | ||||
Q. COMMITMENTS AND CONTINGENCIES
Purchase Commitments
As of April 3, 2022, Teradyne had entered into purchase commitments for certain components and materials. The purchase commitments covered by the agreements aggregate to approximately $904.0 million, of which $826.7 million is for less than one year.
Legal Claims
Teradyne is subject to various legal proceedings and claims which have arisen in the ordinary course of business such as, but not limited to, patent, employment, commercial and environmental matters. Teradyne believes that it has meritorious defenses against all pending claims and intends to vigorously contest them. While it is not possible to predict or determine the outcomes of any pending claims or to provide possible ranges of losses that may arise, Teradyne believes the potential losses associated with all of these actions are unlikely to have a material adverse effect on its business, financial position or results of operations.
On March 8, 2021, Industrial Automation LLC, sellers of AutoGuide, submitted a demand for arbitration against Teradyne and AutoGuide in Wilmington, Delaware alleging that Teradyne and AutoGuide breached certain provisions of the Membership Interests Purchase Agreement (the “Purchase Agreement”), dated as of October 18, 2019, among Industrial Automation LLC, Teradyne and AutoGuide. The arbitration demand sought
ful
l acceleration of the maximum earn-out amount payable under the Purchase Agreement, or $106.9
million, for the alleged breach of the earn-out provisions of the Purchase Agreement. On March 21, 2022, the arbitration claim was settled for
$26.7
million. As a result, Teradyne has no remaining earn-
out
obligations.
Guarantees and Indemnification Obligations
Teradyne provides indemnification, to the extent permitted by law, to its officers, directors, employees and agents for liabilities arising from certain events or occurrences, while the officer, director, employee, or agent, is or was serving, at Teradyne’s request in such capacity. Teradyne may enter into indemnification agreements with certain of its officers and directors. With respect to acquisitions, Teradyne provides indemnifications to or assumes indemnification obligations for the current and former directors, officers and employees of the acquired companies in accordance with the acquired companies’ by-laws and charter. As a matter of practice, Teradyne has maintained directors’ and officers’ liability insurance coverage including coverage for directors and officers of acquired companies.
Teradyne enters into agreements in the ordinary course of business with customers, resellers, distributors, integrators and suppliers. Most of these agreements require Teradyne to defend and/or indemnify the other party against intellectual property infringement claims brought by a third party with respect to Teradyne’s products. From time to time, Teradyne also indemnifies customers and business partners for damages, losses and liabilities they may suffer or incur relating to personal injury, personal property damage, product liability, breach of confidentiality obligations and environmental claims relating to the use of Teradyne’s products and services or resulting from the acts or omissions of Teradyne, its employees, authorized agents or subcontractors. On occasion, Teradyne has also provided guarantees to customers regarding the delivery and performance of its products in addition to the warranty described below.
As a matter of ordinary course of business, Teradyne warrants that its products will substantially perform in accordance with its standard published specifications in effect at the time of delivery. Most warranties have a one-year duration commencing from installation. A provision is recorded upon revenue recognition to cost of revenues for estimated warranty expense based upon historical experience. When Teradyne receives revenue for extended warranties beyond the standard duration, the revenue is deferred and recognized on a straight-line basis over the contract period. Related costs are expensed as incurred. As of April 3, 2022 and December 31, 2021, Teradyne had a product warranty accrual of $20.1 million and $24.6 million, respectively, included in other accrued liabilities, and revenue deferrals related to extended warranties of $65.7 million and $64.2 million, respectively, included in short and long-term deferred revenue and customer advances.
In addition, in the ordinary course of business, Teradyne provides minimum purchase guarantees to certain vendors to ensure continuity of supply against the market demand. Although some of these guarantees provide penalties for cancellations and/or modifications to the purchase commitments as the market demand decreases, most of the guarantees do not. Therefore, as the market demand decreases, Teradyne re-evaluates these guarantees and determines what charges, if any, should be recorded.
With respect to its agreements covering product, business or entity divestitures and acquisitions, Teradyne provides certain representations, warranties and covenants to purchasers and agrees to indemnify and hold such purchasers harmless against breaches of such representations, warranties and covenants. Many of the indemnification claims have a definite expiration date while some remain in force indefinitely. With respect to its acquisitions, Teradyne may, from time to time, assume the liability for certain events or occurrences that took place prior to the date of acquisition.
As a matter of ordinary course of business, Teradyne occasionally guarantees certain indebtedness obligations of its subsidiary companies, limited to the borrowings from financial institutions, purchase commitments to certain vendors, and lease commitments to landlords.
Based on historical experience and information known as of April 3, 2022 and December 31, 2021, except for product warranty, Teradyne has not recorded any liabilities for these guarantees and obligations because the amount would be immaterial.
R. INCOME TAXES
A reconciliation of the United States federal statutory corporate tax rate to Teradyne’s effective tax rate was as follows:
| For the Three Months Ended | ||||||||
| April 3, 2022 | April 4, 2021 | |||||||
| US statutory federal tax rate | 21.0 | % | 21.0 | % | ||||
| Non-deductible officers’ compensation | 1.1 | 0.8 | ||||||
| Discrete benefit related to equity compensation | (6.6 | ) | (6.2 | ) | ||||
| Foreign taxes | (3.4 | ) | (4.7 | ) | ||||
| Tax credits | (1.6 | ) | (1.3 | ) | ||||
| International provisions of the U.S. Tax Cuts and Jobs Act of 2017 | (1.3 | ) | (1.5 | ) | ||||
| Other, net | 1.0 | 0.2 | ||||||
| Effective tax rate | 10.2 | % | 8.3 | % | ||||
On a quarterly basis, Teradyne evaluates the realizability of the deferred tax assets by jurisdiction and assesses the need for a valuation allowance. As of April 3, 2022, Teradyne believes that it will ultimately realize the deferred tax assets recorded on the condensed consolidated balance sheet. However, should Teradyne believe that it is
more-likely-than-not
that the deferred tax assets would not be realized, the tax provision would increase in the period in which Teradyne determined that the realizability was not likely. Teradyne considers the probability of future taxable income and historical profitability, among other factors, in assessing the realizability of the deferred tax assets.
As of April 3, 2022 and December 31, 2021, Teradyne had $14.6 million and $14.5 million, respectively, of reserves for uncertain tax positions. The $0.1 million net increase in reserves for uncertain tax positions is related to U.S. federal research and development credits generated in the current year.
As of April 3, 2022, Teradyne estimates that it is reasonably possible that the balance of unrecognized tax benefits may decrease approximately $0.2 million in the next twelve months because of a lapse of statutes of limitation. The estimated decrease relates to loss carryforwards.
Teradyne recognizes interest and penalties related to income tax matters in income tax expense. As of April 3, 2022 and December 31, 2021, $0.3 million and $0.3 million, respectively, of interest and penalties were accrued for uncertain tax positions. For the three months ended April 3, 2022 and April 4, 2021, expense of $0.1 million and $0.1 million, respectively, was recorded for interest and penalties related to income tax items.
Teradyne qualifies for a tax holiday in Singapore by fulfilling the requirements of an agreement with the Singapore Economic Development Board under which certain headcount and spending requirements must be met. The tax savings due to the tax holiday for the three months ended April 3, 2022 was $3.5 million, or $0.02 per diluted share. The tax savings due to the tax holiday for the three months ended April 4, 2021 was $6.2 million, or $0.03 per diluted share. In November 2020, Teradyne entered into an agreement with the Singapore Economic Development Board which extended our Singapore tax holiday under substantially similar terms to the agreement which expired on December 31, 2020. The new tax holiday is scheduled to expire on December 31, 2025.
S. SEGMENT INFORMATION
Teradyne has four reportable segments (Semiconductor Test, System Test, Industrial Automation and Wireless Test). Each of the reportable segments is also an individual operating segment.
The Semiconductor Test segment includes operations related to the design, manufacturing and marketing of semiconductor test products and services. The System Test segment includes operations related to the design, manufacturing and marketing of products and services for defense/aerospace instrumentation test, storage and system level test, and circuit-board test. The Industrial Automation segment includes operations related to the design, manufacturing and marketing of collaborative robotic arms, autonomous mobile robots and advanced robotic control software. The Wireless Test segment includes operations related to the design, manufacturing and marketing of wireless test products and services. Each operating segment has a segment manager who is directly accountable to and maintains regular contact with Teradyne’s chief operating decision maker (Teradyne’s chief executive officer) to discuss operating activities, financial results, forecasts, and plans for the segment.
Teradyne evaluates performance based on several factors, of which the primary financial measure is business segment income (loss) before income taxes. The accounting policies of the business segments in effect are described in Note B: “Accounting Policies” in Teradyne’s Annual Report on Form
10-K
for the year ended December 31, 2021.
Segment information for the three months ended April 3, 2022 and April 4, 2021 is as follows:
| Semiconductor Test | System Test | Industrial Automation | Wireless Test | Corporate and Eliminations | Consolidated | |||||||||||||||||||
| (in thousands) | ||||||||||||||||||||||||
| Three Months Ended April 3, 2022 | ||||||||||||||||||||||||
| Revenues | $ | 482,341 | $ | 118,668 | $ | 103,189 | $ | 51,518 | $ | (346 | ) | $ | 755,370 | |||||||||||
| Income (loss) before income taxes (1)(2) | 149,705 | 41,322 | (5,098 | ) | 18,619 | (24,189 | ) | 180,359 | ||||||||||||||||
| Total assets (3) | 1,296,070 | 187,283 | 675,560 | 113,821 | 1,336,420 | 3,609,154 | ||||||||||||||||||
| Three Months Ended April 4, 2021 | ||||||||||||||||||||||||
| Revenues | $ | 528,063 | $ | 132,837 | $ | 79,951 | $ | 40,898 | $ | (143 | ) | $ | 781,606 | |||||||||||
| Income (loss) before income taxes (1)(2) | 176,368 | 51,061 | (12,967 | ) | 9,616 | (85 | ) | 223,993 | ||||||||||||||||
| Total assets (3) | 1,243,358 | 179,195 | 672,596 | 104,367 | 1,520,201 | 3,719,717 |
| (1) | Included in Corporate and Eliminations are: legal fees, contingent consideration fair value adjustments, interest income, interest expense, severance charges, net foreign exchange gains (losses), acquisition related charges and compensation, intercompany eliminations and for the three months ended April 4, 2021, loss on convertible debt conversions. |
|---|
| (2) | Included in income (loss) before taxes are charges and credits related to restructuring and other, inventory charges and, for the three months ended April 4, 2021, loss on convertible debt conversions. |
|---|
| (3) | Total assets are attributable to each segment. Corporate assets consist of cash and cash equivalents, marketable securities, and certain other assets. |
|---|
Included in each segment are charges and credits in the following line items in the statements of operations:
| For the Three Months Ended | ||||||||
| April 3, 2022 | April 4, 2021 | |||||||
| (in thousands) | ||||||||
| Semiconductor Test: | ||||||||
| Cost of revenues—inventory charge | $ | — | $ | 1,079 | ||||
| Industrial Automation: | ||||||||
| Cost of revenues—inventory charge | $ | — | $ | 1,221 | ||||
| Wireless: | ||||||||
| Cost of revenues—inventory charge | $ | 877 | $ | — | ||||
| Corporate and Eliminations : | ||||||||
| Restructuring and other— legal settlement charge | $ | 14,700 | $ | — | ||||
| Restructuring and other—AutoGuide contingent consideration adjustment | — | (7,227 | ) | |||||
| Other (income) expense, net—loss on convertible debt conversion s | — | 4,069 | ||||||
| Restructuring and other—acquisition related expenses and compensation | — | (513 | ) |
T. SHAREHOLDERS’ EQUITY
Stock Repurchase Program
In January 2021, Teradyne’s Board of Directors cancelled the January 2020 repurchase program and approved a new repurchase program for up to $2.0 billion of common stock. Teradyne intends to repurchase a minimum of $750.0 million of its common stock
in
During
the three months ended April 3, 2022, Teradyne repurchased 1.8 million shares of common stock for $201.5 million at an average price of $115.12 per share. During the three months ended April 4, 2021, Teradyne repurchased 0.4 million shares of common stock for $45.2 million at an average price of $120.73 per share. The cumulative repurchases under the $2.0 billion common stock repurchase program as of April 3, 2022 were 6.5 million shares of common stock for $801.5 million at an average price per share of $122.89.
The total price includes commissions and is recorded as a reduction to retained earnings.
Dividend
Holders of Teradyne’s common stock are entitled to receive dividends when they are declared by Teradyne’s Board of Directors.
In January 2022, Teradyne’s Board of Directors declared a 10% increase in the quarterly cash dividend to $0.11 per share. Dividend payments for the three months ended April 3, 2022 were $17.9 million. In January 2021, Teradyne’s Board of Directors declared a quarterly cash dividend of $0.10 per share. Dividend payments for the three months ended April 4, 2021 were $16.7 million.
While Teradyne declared a quarterly cash dividend and authorized a share repurchase program, it may reduce or eliminate the cash dividend or share repurchase program in the future. Future cash dividends and stock repurchases are subject to the discretion of Teradyne’s Board of Directors which will consider, among other things, Teradyne’s earnings, capital requirements and financial condition.
Previous: Cover and table of contents · Next: Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations